SPONSOR
Frontera Therapeutics
Total Trials
2
Recruiting
2
Phases
EARLY_Phase 1, Phase 1
Frontera Therapeutics is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including X-Linked Retinitis Pigmentosa, Diabetic Macular Edema.
The trial portfolio spans EARLY_Phase 1, Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Frontera Therapeutics
How many clinical trials has Frontera Therapeutics sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Frontera Therapeutics, of which 2 are actively recruiting participants. These trials cover conditions including X-Linked Retinitis Pigmentosa, Diabetic Macular Edema. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Frontera Therapeutics research focus on?
Frontera Therapeutics clinical trials span X-Linked Retinitis Pigmentosa, Diabetic Macular Edema. The research pipeline includes EARLY_Phase 1, Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Frontera Therapeutics clinical trial?
To participate in a Frontera Therapeutics trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Frontera Therapeutics trials with current recruitment status updated daily.
Clinical Trials by Frontera Therapeutics
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology